U08, Piano: P02, Stanza: 2043
Via Cadore 48 - 20900 MONZA
Associate professor
Academic disciplines: 
Reception Hours: 

By appointment.


Prof. Lucio Tremolizzo is specialist in neurology (2008) and PhD in neuroscience (2003). He is consultant neurologist at the “San Gerardo” hospital of Monza, and in particular at the Memory Clinic and at the ALS center of the Neurology Unit. At the same time, he coordinates the research projects of Prof. Ferrarese’s LabNeuBio at the UNIMIB.

From 2001 to 2003, Prof. Tremolizzo was post-doctoral research assistant at the University of Illinois at Chicago, USA. From 2005 to 2006, he was honorary research assistant at the University College London and he obtained the PGDip in Clinical Neurology at the “Queen Square” Institute of Neurology (2006). He also obtained a Master degree in Cerebrovascular Diseases (2010) at the UNIMIB.

Prof. Tremolizzo’s scientific interests are related to dementia and amyotrophic lateral sclerosis, with special reference to biological mechanisms of behavioral disturbances.


  • Bomba, M., Nicosia, F., Riva, A., Corbetta, F., Conti, E., Lanfranconi, F., et al. (2020). QTc dispersion and interval changes in drug-free borderline personality disorder adolescents. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 29(2), 199-203.
  • Tremolizzo, L., Lizio, A., Santangelo, G., Diamanti, S., Lunetta, C., Gerardi, F., et al. (2020). ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability. NEUROLOGICAL SCIENCES, 41(4), 835-841.
  • Peters, S., Vlaanderen, J., Portengen, L., Vermeulen, R., Peters, S., Visser, A., et al. (2020). Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY, 91(1), 33-39.
  • Francioni, V., Pirro, F., D'Anna, G., Cairo, M., Appollonio, I., Ferrarese, C., et al. (2020). DWI/FLAIR Mismatch during Hyperacute Infarction of the Percheron Artery: Time Is Thalamus!. CASE REPORTS IN NEUROLOGY, 12(1), 127-130.
  • Loffreda, A., Nizzardo, M., Arosio, A., Ruepp, M., Calogero, R., Volinia, S., et al. (2020). miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis. PROGRESS IN NEUROBIOLOGY.